ORIGINAL ARTICLE
TC2 C776G polymorphism studies in patients with oral cancer in the Polish population
1
Department of Chemistry and Clinical Biochemistry, Medical University of Lodz, Poland
2
Department of Head and Neck Neoplasms Surgery, Medical University of Lodz, Poland
Submission date: 2015-05-20
Final revision date: 2016-03-13
Acceptance date: 2016-03-21
Publication date: 2016-11-25
Corresponding author
Katarzyna Malinowska
Department of Chemistry and Clinical Biochemistry Medical University of Lodz Hallera 1 square 90-647 Lodz, Poland
Department of Chemistry and Clinical Biochemistry Medical University of Lodz Hallera 1 square 90-647 Lodz, Poland
Pol J Pathol 2016;67(3):277-282
KEYWORDS
TOPICS
ABSTRACT
The first signs of oral cancer may resemble developing infections in the mucous membranes, with throat cancer symptoms being similar to those of upper respiratory tract infections. This greatly hinders rapid diagnosis and treatment. Better knowledge of the changes occurring in the metabolism of folic acid can help in understanding the carcinogenesis affecting DNA methylation and genome stability. Polymorphisms in genes encoding enzymes involved in this pathway may influence enzyme activity and thereby interfere with the concentrations of homocysteine and S-adenosylmethionine, which are important for DNA synthesis and cellular methylation reactions. The aim of the study was to determine the risk of oral cancer associated with the TC2 C776G polymorphism, as determined in 119 patients. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The test genotype was found to correspond to the Hardy-Weinberg (HW) equilibrium (p > 0.05). In our population G/G homozygosity of C776G TC2 gene polymorphism increases the risk of oral cancer; OR (odds ratio): 4.3875; 95% CI (confidence interval): 2.0518-9.319; p = 0.001. Regarding C/G genotype of the C776G TC2 gene, polymorphism also increases the risk of developing this cancer; OR 2.4146 95% CI: 1.2803-4.5541; p = 0.01.
REFERENCES (36)
1.
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2.
Ferlay J, Shin RH, Bray F, et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 2008; 127: 2893-2917.
3.
Olivieri EHR, da Silva SD, Mendonc’a FF, et al. CYP1A2*1C,CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncol 2009; 45: 73-79.
4.
Wang Y, Guo W, He Y, et al. Association of MTHFR C677T and SHMT1 C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control 2007; 18: 143-152.
5.
Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dental Research 2007; 86: 104-114.
6.
Argiris A, Karamouzis VM, Raben D. Head and neck cancer. Lancet 2008; 371: 1695-1709.
7.
Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997; 94: 3290-3295.
8.
Namour F, Guy M, Aimone-Gastin I, et al. Isoelectrofocusing phenotype and relative concentration of transcobalamin II isoproteins related to the codon 259 Arg/Pro polymorphism. Biochem Biophys Res Commun 1998; 251: 769-774.
9.
Wang Y, Guo W, He Y, Chen Z, Wen D, et al. Association of MTHFR C677T and SHMT1 C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. Cancer Causes Control 2007; 18: 143-152.
10.
Wang L, Lu J, An J, et al. Polymorphisms of cytosolic serine hydroxyl-methyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer 2007; 57: 143-151.
11.
Ma E, Iwasaki M, Junko I, et al. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer 2009; 9: 122.
12.
Linhart HG, Troen A, Bell GW, et al. Folate deficiency induces genomic uracil misincorporation and hypomethylation but does not increase DNA point mutations. Gastroenterology 2009; 136: 227-235.
13.
Garcia-Crespo D, Knock E, Jabado N, et al. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine. J Nutr 2009; 139: 488-494.
14.
Langevin SM, Lin D, Matsuo K, et al. Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett 2009; 184: 73-80.
15.
Kane MA. The role of folates in squamous cell carcinoma of the head and neck. Cancer Detect Prev 2005; 29: 46-53.
16.
Kim DH. The interactive effect of methyl-group diet and polymorphism of methylenetetrahydrofolate reductase on the risk of colorectal cancer. Mutat Res 2007; 622: 14-18.
17.
Kim Y. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem 1997; 10: 66-88.
18.
Mason JB, Choi SW. Effects of alcohol on folate metabolism: implications for carcinogenesis. Alcohol 2005; 35: 235-241.
19.
Xu X, Gammon MD, Wetmur JG, et al. B-vitamin intake, onecarbon metabolism, and survival in a population based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 8: 2109-2116.
20.
Kalmbach RD, Choumenkovitch SF, Troen AP, et al. A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate. J Nutr 2008; 138: 2323-2327.
21.
Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Clin Nutr 2006; 83: 895-904.
22.
Xu X, Gammon MD, Zeisel SH, et al. Choline metabolism and risk of breast cancer in a populationbased study. FASEB J 2008; 22: 2045-2052.
23.
Hsiung DT, Marsit CJ, Houseman EA, et al. Global DNA methylation levelin whole blood as a biomarker in head and neck squamous cellcarcinoma. Cancer Epidemiol Biomarkers Prev 2006; 16: 108-114.
24.
Charasson V, Hillaire-Buys D, Solassol I, et al. Involvement of gene polymorphisms of the folate pathway enzymes in gene expression and anticancer drug sensitivity using the NCI-60 panel as a model. Eur J Cancer 2009; 45: 2391-2401.
25.
Afman LA, Lievers KJ, Van der Put NM, et al. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 2002; 10: 433-438.
26.
Miller JW, Ramos MI, Garrod N, et al. Transcobalamin II 775GNC polymorphism and indices of vitamin B12 status in healthy older adults. Blood 2002; 15: 718-720.
27.
Biselli JM, Brumati D, Frigeri VF, et al. A80G polymorphism of reduced folate carrier 1 (RFC1) and C776G polymorphism of transcobalamin 2 (TC2) genes in Down’s syndrome etiology. Med J 2008; 126: 329-332.
28.
Noguti J, De Moura CF, De Jesus GP, et al. Metastasis from oral cancer: an overview. Cancer Genomics Proteomics 2012; 9: 329-335.
29.
da Silva LM, Galbiatti AL, Ruiz M, et al. MTHFD1 G1958A, BHMT G742A, TC2 C776G and TC2 A67G polymorphisms and head and neck squamous cell carcinoma risk. Mol Biol Rep 2012; 39: 887-893.
30.
Omar E. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma – a systematic review. Head Face Med 2015; 11: 6. doi: 10.1186/s13005-015-0063.
31.
Dolan RW, Vaughan CW, Fuleihan N. Symptoms in early head and neck cancer: an inadequate indicator. Otolaryngol Head Neck Surg 1998; 119: 463-467.
32.
Wang X, Xu J, Wang L, et al. The role of cigarette smoking and alcohol consumption in the differentiation of oral squamous cell carcinoma for the males in China. J Cancer Res Ther 2015; 11: 141-145.
33.
Mahapatra S, Kamath R, Shetty BK, et al. Risk of oral cancer associated with gutka and other tobacco products: A hospital-based case-control study. J Cancer Res Ther 2015; 11: 199-203.
34.
Zhang Y, Wang R, Miao L, et al. Different levels in alcohol and tobacco consumption in head and neck cancer patients from 1957 to 2013. PLoS One 2015; 10: 0124045.
35.
Hazra A, Wu K, Kraft P, et al. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses’ Health Study. Carcinogenesis 2007; 28: 1510-1519.
36.
Curtin K, Slattery M, Ulrich CM, et al. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 2007; 28: 1672-1679.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
